|
ATCC
hcc1806 Hcc1806, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/hcc1806/product/ATCC Average 97 stars, based on 1 article reviews
hcc1806 - by Bioz Stars,
2026-06
97/100 stars
|
Buy from Supplier |
|
ATCC
ovcar3 Ovcar3, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/ovcar3/product/ATCC Average 97 stars, based on 1 article reviews
ovcar3 - by Bioz Stars,
2026-06
97/100 stars
|
Buy from Supplier |
|
Procell Inc
hcc1806 ![]() Hcc1806, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/hcc1806/product/Procell Inc Average 86 stars, based on 1 article reviews
hcc1806 - by Bioz Stars,
2026-06
86/100 stars
|
Buy from Supplier |
|
ATCC
hcc1806 cells ![]() Hcc1806 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/hcc1806 cells/product/ATCC Average 97 stars, based on 1 article reviews
hcc1806 cells - by Bioz Stars,
2026-06
97/100 stars
|
Buy from Supplier |
|
ATCC
hcc1806 atcc crl ![]() Hcc1806 Atcc Crl, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/hcc1806 atcc crl/product/ATCC Average 99 stars, based on 1 article reviews
hcc1806 atcc crl - by Bioz Stars,
2026-06
99/100 stars
|
Buy from Supplier |
|
ATCC
triple negative breast cancer cell line hcc1806 ![]() Triple Negative Breast Cancer Cell Line Hcc1806, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/triple negative breast cancer cell line hcc1806/product/ATCC Average 97 stars, based on 1 article reviews
triple negative breast cancer cell line hcc1806 - by Bioz Stars,
2026-06
97/100 stars
|
Buy from Supplier |
Journal: Nucleic Acids Research
Article Title: In situ tracking of glycoRNAs on single-cell surface to reveal RNA heterogeneity and transport mechanism
doi: 10.1093/nar/gkag362
Figure Lengend Snippet: GLINT visualization of glycoRNA content changes during breast cancer malignant transformation. ( A–E ) Confocal images and single-cell fluorescence histograms of MCF-10A, MCF-7, BT474, SK-BR-3, MDA-MB-361, BT549 HS578t, MDA-MB-436, HCC1806, and MDA-MB-231 cells obtained via GLINT combined with T RNA-U1 , T RNA-U3 , T RNA-U35a , T RNA-Y5 , T RNA-U8 .
Article Snippet: MCF-7cells were obtained from China Center for Type Culture Collection (CTCC), while MCF-10A, SK-BR-3, MDA-MB-231, BT549, Hs578T,
Techniques: Transformation Assay, Single Cell, Fluorescence
Journal: NeuroSci
Article Title: The Knockout of Protocadherin Gamma C3 (PCDHGC3) in Breast Cancer and Melanoma Cell Lines Leads to Increased Adhesion of Knockout Cells to Brain Microvascular Endothelial Cells
doi: 10.3390/neurosci7020047
Figure Lengend Snippet: Generation of PCDHGC3 knockout in breast cancer and melanoma cell lines. Western blot analysis of wild type (WT), control (C; transfected with the PCDH2 HDR Plasmid (h2) containing a puromycin resistance gene) and knockout (KO) HCC1806 breast cancer cell line ( a ) and A2058 melanoma cell line ( b ). β-Actin served as an endogenous control.
Article Snippet:
Techniques: Knock-Out, Western Blot, Control, Transfection, Plasmid Preparation
Journal: NeuroSci
Article Title: The Knockout of Protocadherin Gamma C3 (PCDHGC3) in Breast Cancer and Melanoma Cell Lines Leads to Increased Adhesion of Knockout Cells to Brain Microvascular Endothelial Cells
doi: 10.3390/neurosci7020047
Figure Lengend Snippet: Cell proliferation assay in control and PCDHGC3 knockout cells. Proliferation rate of control and PCDHGC3 knockout (KO) HCC1806 breast cancer cells ( a ) and of control and PCDHGC3 KO A2058 melanoma cells ( b ). **** = p < 0.0001, unpaired t test.
Article Snippet:
Techniques: Proliferation Assay, Control, Knock-Out
Journal: NeuroSci
Article Title: The Knockout of Protocadherin Gamma C3 (PCDHGC3) in Breast Cancer and Melanoma Cell Lines Leads to Increased Adhesion of Knockout Cells to Brain Microvascular Endothelial Cells
doi: 10.3390/neurosci7020047
Figure Lengend Snippet: Relative adhesion of PCDHGC3 knockout breast cancer and melanoma cells to human in vitro BBB models. Adhesion measurements of HCC1806 PCDHGC3 knockout (KO) and control cells to hCMEC/D3 ( a ) and BLECs ( b ) after 30, 60, and 120 min. Adhesion measurements of A2058 PCDHGC3 knockout (KO) and control cells to hCMEC/D3 ( c ) and BLECs ( d ) after 30, 60, and 120 min. Control cell adhesion was measured at each time point; however, for clarity, only the measurement after 30 min is shown. Data are presented as mean relative adhesion versus control with standard deviation, **** = p ≤ 0.0001, one-way ANOVA test.
Article Snippet:
Techniques: Knock-Out, In Vitro, Control, Standard Deviation
Journal: NeuroSci
Article Title: The Knockout of Protocadherin Gamma C3 (PCDHGC3) in Breast Cancer and Melanoma Cell Lines Leads to Increased Adhesion of Knockout Cells to Brain Microvascular Endothelial Cells
doi: 10.3390/neurosci7020047
Figure Lengend Snippet: PCDHGC3 KO leads to stronger invasion of PCDHGC3 knockout breast cancer and melanoma cells. HCC1806 PCDHGC3 knockout (KO) and control cells ( a ) and A2058 PCDHGC3 knockout (KO) and control ( b ) invaded for 48 h through Transwells coated with Matrigel. The number of invaded cells is shown. Data are presented as mean cell number with standard deviation, * = p ≤ 0.05, unpaired t -test.
Article Snippet:
Techniques: Knock-Out, Control, Standard Deviation
Journal: NeuroSci
Article Title: The Knockout of Protocadherin Gamma C3 (PCDHGC3) in Breast Cancer and Melanoma Cell Lines Leads to Increased Adhesion of Knockout Cells to Brain Microvascular Endothelial Cells
doi: 10.3390/neurosci7020047
Figure Lengend Snippet: Relative expression of target genes in PCDHGC3 KO breast cancer and melanoma cells. The relative expression (RQ value) of each target in PCDHGC3 KO HCC1806 ( a ) and PCDHGC3 KO A2058 ( b ) cells relative to control cells is shown. A RQ value < 1.0 indicates decreased expression, a RQ value > 1.0 indicates increased expression compared to the control cells. The means with standard deviation are shown as the fold of the control. * = p ≤ 0.05, ** = p ≤ 0.01, *** = p ≤ 0.001, **** = p ≤ 0.0001, unpaired t -test.
Article Snippet:
Techniques: Expressing, Control, Standard Deviation
Journal: NeuroSci
Article Title: The Knockout of Protocadherin Gamma C3 (PCDHGC3) in Breast Cancer and Melanoma Cell Lines Leads to Increased Adhesion of Knockout Cells to Brain Microvascular Endothelial Cells
doi: 10.3390/neurosci7020047
Figure Lengend Snippet: Matrix metalloproteinase (MMP) activity in cell culture medium of PCDHGC3 knockout (KO) breast cancer and melanoma cells. Fluorescence signal of MMP-substrate (SB) cleavage in the cell culture medium of PCDHGC3 KO HCC1806 ( a ) and PCDHGC3 KO A2058 ( b ) cells and control cells is expressed as relative fluorescence units (RFU) ± standard deviation. ** = p < 0.01, *** = p < 0.001, unpaired t test.
Article Snippet:
Techniques: Activity Assay, Cell Culture, Knock-Out, Fluorescence, Control, Standard Deviation